Clinical Trials Browser

Phase 2 × Adenocarcinoma of the Prostate × STA 9090 × Clear all

NCT01368003 2015-09-01

STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling

Phase 2 Withdrawn

Adenocarcinoma of the Prostate